Electroacupuncture vs Prucalopride for Severe Chronic Constipation: A Multicenter, Randomized, Controlled, Noninferiority Trial

American Journal of Gastroenterology

Volumn 116, Issue 5, 2021, Pages 1024-1035

  Liu, Baoyan ^a   Wu, Jiani ^a   Yan, Shiyan ^a   Zhou, Kehua ^b   He, Liyun ^a   Fang, Jianqiao ^c   Fu, Wenbin ^d   Li, Ning ^e   Su, Tongsheng ^f   Sun, Jianhua ^g   Zhang, Wei ^h   Yue, Zenghui ⁱ   Zhang, Hongxing ^j   Zhao, Jiping ^k   Zhou, Zhongyu ^l   Song, Hujie ^m   Wang, Jian ⁿ   Liu, Li'an ^o   Wang, Linpeng ^p   Lv, Xiaoying ^a   Yang, Xiaofang ^q   Liu, Yan ^k   Sun, Yuanjie ^a   Wang, Yang ^a   Qin, Zongshi ^a   Zhou, Jing ^a   Liu, Zhishun ^a   more..

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b UNIVERSITY AT BUFFALO   (United States)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^d GUANGDONG PROVINCIAL HOSPITAL OF CHINESE MEDICINE   (China)

^e SICHUAN UNIVERSITY   (China)

^f Chinese Medicine Hospital of Shanxi Province   (China)

^g THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^h THE FIRST HOSPITAL OF HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

ⁱ HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

^j Wuhan Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^k BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^l HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

^m TCM Hospital of Xi'an   (China)

ⁿ AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^o Hiser Medical Center   (China)

^p BEIJING HOSPITAL OF TRADITIONAL CHINESE MEDICINE AFFILIATED TO CAPITAL MEDICAL UNIVERSITY   (China)

^q GUIZHOU UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BISACODYL; GLYCEROL; PRUCALOPRIDE; BENZOFURAN DERIVATIVE; LAXATIVE;

ABDOMINAL PAIN; ADULT; ARTICLE; BLOATING; CHINA; CHRONIC CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DYSPEPSIA; ELECTROACUPUNCTURE; FEMALE; FEVER; HEADACHE; HEART PALPITATION; HEMATOMA; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; NON-INFERIORITY TRIAL; PAIN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECTAL TENESMUS; VOMITING; CHRONIC DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CONSTIPATION; EQUIVALENCE TRIAL (TOPIC); MIDDLE AGED; PROCEDURES;

BENZOFURANS; CHINA; CHRONIC DISEASE; CONSTIPATION; ELECTROACUPUNCTURE; EQUIVALENCE TRIALS AS TOPIC; FEMALE; HUMANS; LAXATIVES; MALE; MIDDLE AGED;

EID: 85106068907     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.14309/ajg.0000000000001050     Document Type: Article

References (53)

1. Mugie SM, Benninga MA, Di Lorenzo C,. Epidemiology of constipation in children and adults: A systematic review. Best Pract Res Clin Gastroenterol 2011; 25: 3-18.
2. Peery AF, Crockett SD, Barritt AS, et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 2015; 149: 1731-41.e3.
3. Tack J, van Outryve M, Beyens G, et al. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009; 58: 357-65.
4. Quigley EM, Vandeplassche L, Kerstens R, et al. Clinical trial: The efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation: a 12-week, randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 2009; 29: 315-28.
5. Camilleri M, Kerstens R, Rykx A, et al. A placebo-controlled trial of prucalopride for severe chronic constipation. N Engl J Med 2008; 358: 2344-54.
6. Wald A, Scarpignato C, Kamm MA, et al. The burden of constipation on quality of life: Results of a multinational survey. Aliment Pharmacol Ther 2007; 26: 227-36.
7. Nelson AD, Camilleri M, Chirapongsathorn S, et al. Comparison of efficacy of pharmacological treatments for chronic idiopathic constipation: A systematic review and network meta-analysis. Gut 2017; 66: 1611-22.
8. Johanson JF, Kralstein J,. Chronic constipation: A survey of the patient perspective. Aliment Pharmacol Ther 2007; 25: 599-608.
9. Johnson DA,. Treating chronic constipation: How should we interpret the recommendations? Clin Drug Investig 2006; 26: 547-57.
10. Bouras EP, Camilleri M, Burton DD, et al. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans. Gut 1999; 44: 682-6.
11. De Schryver AM, Andriesse GI, Samsom M, et al. The effects of the specific 5HT(4) receptor agonist, prucalopride, on colonic motility in healthy volunteers. Aliment Pharmacol Ther 2002; 16: 603-12.
12. Coremans G, Kerstens R, De Pauw M, et al. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial. Digestion 2003; 67: 82-9.
13. Luthra P, Camilleri M, Burr NE, et al. Efficacy of drugs in chronic idiopathic constipation: A systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2019; 4: 831-44.
14. US Food and Drug Administration. FDA Briefing Document: Gastrointestinal Drug Advisory Committee Meeting, Bethesda, Maryland, October 18, 2018.
15. European Medicines Agency. Annex I. Summary of Product Characteristics Resolor. European Medicines Agency: London, UK, 2014.
16. Schneider A, Streitberger K, Joos S,. Acupuncture treatment in gastrointestinal diseases: A systematic review. World J Gastroenterol 2007; 13: 3417-24.
17. Zhang T, Chon TY, Liu B, et al. Efficacy of acupuncture for chronic constipation: A systematic review. Am J Chin Med 2013; 41: 717-42.
18. Liu Z, Yan S, Wu J, et al. Acupuncture for chronic severe functional constipation: A randomized trial. Ann Intern Med 2016; 165: 761-9.
19. Wang Y, Liu Y, Zhou K, et al. The duration of acupuncture effects and its associated factors in chronic severe functional constipation: Secondary analysis of a randomized controlled trial. Therap Adv Gastroenterol 2019; 12: 1756284819881859.
20. Wang L, Xu M, Zheng Q, et al. The effectiveness of acupuncture in management of functional constipation: A systematic review and meta-analysis. Evid Based Complement Alternat Med 2020; 2020: 6137450.
21. Longstreth GF, Thompson WG, Chey WD, et al. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91.
22. WHO Regional Office for the Western Pacific. WHO Standard Acupuncture Point Locations in the Western Pacific Region. World Health Organization Pr: Geneva, Switzerland, 2008.
23. Xun Jin YD, Ding Shu-Qing, Jiang Bin, et al. Evaluation of the Chinese version of the patient assessment of constipation quality of life scale. World Chin J Digestology 2011; 19: 209-13.
24. European Medicines Agency. Guideline on the Evaluation of Medicinal Products for the Treatment of Chronic Constipation (Including Opioid Induced Constipation) and for Bowel Cleansing. 2016 (http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2015/09/WC500193391.pdf). Accessed February 2, 2017.
25. Lewis SJ, Heaton KW,. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol 1997; 32: 920-4.
26. Marquis P, De la Loge C, Dubois D, et al. Development and validation of the patient assessment of constipation quality of life questionnaire. Scand J Gastroenterol 2005; 40: 540-51.
27. Wu J, Zhang B, Xu H, et al. Effect of electro-acupuncture for chronic severe functional constipation: A randomized controlled pilot trial (Chinese). China J Traditional Chin Med Pharm 2014; 29: 1424-8.
28. Postma DF, van Werkhoven CH, van Elden LJ, et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. N Engl J Med 2015; 372: 1312-23.
29. Nager CW, Brubaker L, Litman HJ, et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med 2012; 366: 1987-97.
30. Ke M, Tack J, Quigley EM, et al. Effect of prucalopride in the treatment of chronic constipation in asian and non-Asian women: A pooled analysis of 4 randomized, placebo-controlled studies. J Neurogastroenterol Motil 2014; 20: 458-68.
31. Yiannakou Y, Piessevaux H, Bouchoucha M, et al. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation. Am J Gastroenterol 2015; 110: 741-8.
32. Schafer JL,. Multiple imputation: A primer. Stat Methods Med Res 1999; 8: 3-15.
33. Stewart W,. Epidemiology of constipation (EPOC) study in the United States: Relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999; 94: 3530-40.
34. Luo D, Liu S, Xie X, et al. Electroacupuncture at acupoint ST-36 promotes contractility of distal colon via a cholinergic pathway in conscious rats. Dig Dis Sci 2008; 53: 689-93.
35. Wang X, Yang B, Yin J, et al. Electroacupuncture via chronically implanted electrodes improves gastrointestinal motility by balancing sympathovagal activities in a rat model of constipation. Am J Physiol Gastrointest Liver Physiol 2019; 316: G797-G805.
36. Du F, Liu S,. Electroacupuncture with high frequency at acupoint ST-36 induces regeneration of lost enteric neurons in diabetic rats via GDNF and PI3K/AKT signal pathway. Am J Physiol Regul Integr Comp Physiol 2015; 309: R109-18.
37. Liang C, Wang KY, Gong MR, et al. Electro-acupuncture at ST37 and ST25 induce different effects on colonic motility via the enteric nervous system by affecting excitatory and inhibitory neurons. Neurogastroenterol Motil 2018; 30: e13318.
38. Ge Z, Duan Z, Yang H, et al. Home-based transcutaneous neuromodulation improved constipation via modulating gastrointestinal hormones and bile acids. Evid Based Complement Alternat Med 2018; 2018: 2086163.
39. Jiang Y, Wang H, Liu Z, et al. Manipulation of and sustained effects on the human brain induced by different modalities of acupuncture: An fMRI study. PLoS One 2013; 8: e66815.
40. Long X, Huang W, Napadow V, et al. Sustained effects of acupuncture stimulation investigated with centrality mapping analysis. Front Hum Neurosci 2016; 10: 510.
41. MacPherson H, Tilbrook H, Richmond S, et al. Alexander technique lessons or acupuncture sessions for persons with chronic neck pain: A randomized trial. Ann Intern Med 2015; 163: 653-62.
42. Ke M, Zou D, Yuan Y, et al. Prucalopride in the treatment of chronic constipation in patients from the asia-pacific region: A randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil 2012; 24: 999-e541.
43. Pei L, Geng H, Guo J, et al. Effect of acupuncture in patients with irritable bowel syndrome: A randomized controlled trial. Mayo Clin Proc 2020; 95: 1671-83.
44. American Gastroenterological Association; Bharucha AE, Dorn SD, Lembo A, et al. American Gastroenterological Association medical position statement on constipation. Gastroenterology 2013; 144: 211-7.
45. Francis CY, Morris J, Whorwell PJ,. The irritable bowel severity scoring system: A simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11: 395-402.
46. Vriesman MH, Koppen IJN, Camilleri M, et al. Management of functional constipation in children and adults. Nat Rev Gastroenterol Hepatol 2020; 17: 21-39.
47. Kaptchuk TJ, Kelley JM, Conboy LA, et al. Components of placebo effect: Randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008; 336: 999-1003.
48. Paterson C, Dieppe P,. Characteristic and incidental (placebo) effects in complex interventions such as acupuncture. BMJ 2005; 330: 1202-5.
49. Carrington EV, Evers J, Grossi U, et al. A systematic review of sacral nerve stimulation mechanisms in the treatment of fecal incontinence and constipation. Neurogastroenterol Motil 2014; 26: 1222-37.
50. Maeda Y, Kamm MA, Vaizey CJ, et al. Long-term outcome of sacral neuromodulation for chronic refractory constipation. Tech Coloproctol 2017; 21: 277-86.
51. Talley NJ,. Differentiating functional constipation from constipation-predominant irritable bowel syndrome: Management implications. Rev Gastroenterol Disord 2005; 5: 1-9.
52. Tsukayama H, Yamashita H, Kimura T, et al. Factors that influence the applicability of sham needle in acupuncture trials: Two randomized, single-blind, crossover trials with acupuncture-experienced subjects. Clin J Pain 2006; 22: 346-9.
53. Kaptchuk TJ, Stason WB, Davis RB, et al. Sham device v inert pill: Randomised controlled trial of two placebo treatments. BMJ 2006; 332: 391-7.